Beyond Diagnostics We provide products and services that impact one billion people's life in the world. Noul focuses on the most challenging healthcare issues the world has yet to resolve. …

4 days ago · Noul's miLab CER is the solution that automates the overall cervical cancer diagnostic process in 20 minutes, covering key steps from cervical cell slide staining and …

Feb 13, 2025 · For years, Noul has refined its technology, betting that automation can solve one of diagnostics’ biggest inefficiencies: time. Its AI-powered flagship product, the miLab Platform, …

Noul's products are designed to address global health challenges by providing novel diagnostic solutions for diseases such as malaria, tuberculosis, and AIDS. It was founded in 2015 and is …

Noul has filed over 65 global patents, conducted more than seven field clinical trials, and has research partnerships with world-class global institutions.

Information on stock, financials, earnings, subsidiaries, investors, and executives for Noul. Use the PitchBook Platform to explore the full profile.

Sep 2, 2025 · Noul is a public company based in Yongin si (South Korea), founded in 2015 by Kim Tae. It operates as an AI-based digital microscope platform for blood analysis.

Noul Tropical Infectious Diseases Center (Muzuzu, Malawi) Research center focused on diagnosing antibiotic resistant and febrile diseases (Cooperation with Wezi Medical Centre)

Jun 30, 2025 · Founded in December 2015, Noul (376930.KQ) is an on-device AI healthcare company with a mission to explore global challenges that threaten human health and life, …

Noul was established in 2015 with a mission of exploring global challenges that threaten human health and life, discovering novel potential solutions, and realizing those possibilities.